CGC - Canopy Growth Corporation
20.95 +0.17 (0.82%)
Pre-Market: 7:31AM EDT
| Previous Close | 19.73 |
| Open | 20.75 |
| Bid | 0.00 x 900 |
| Ask | 20.95 x 3000 |
| Day's Range | 19.86 - 20.91 |
| 52 Week Range | 17.89 - 52.74 |
| Volume | 6,100,529 |
| Avg. Volume | 4,778,920 |
| Market Cap | 7.212B |
| Beta (3Y Monthly) | 3.67 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.79 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- The Motley Fool
Revealed: The Mind-Boggling Returns Of The TSX 30’s Top Stock
Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) ranks number one on the TSX 30. However, the marquee pot stock is not a great buy today.
- Market Realist
Aphria: Analysts’ Target Price and Ratings after Earnings
Aphria (APHA) reported impressive results for the first quarter of fiscal 2020 on Tuesday. The stock has gained 9.6% since its earnings.
- The Motley Fool
Canopy Growth (TSX:WEED) Teams Up with Seth Rogen’s Houseplant
Pineapple Express actor Seth Rogen founds cannabis brand, Houseplant, with Evan Goldberg and teams up with Canopy Growth (TSX:WEED)(NYSE:CGC).
- Market Realist
Canopy Growth Acquires Beckley Canopy Therapeutics
On October 15, Canopy Growth (CGC) completed the acquisition of cannabinoid-based research company Beckley Canopy Therapeutics.
- Market Realist
Charlotte’s Web Holdings: Analysts’ Target Price and Ratings
As of Tuesday, Charlotte’s Web Holdings was trading at 18.15 Canadian dollars, which implies a fall of 37.0% since its second-quarter earnings on August 14.
CNW GroupHouseplant Introduces New Product Formats And Increases Footprint Across Canada
TORONTO, Oct. 16, 2019 /CNW/ -- Houseplant has introduced Pre-Rolled Joints and Softgel Capsules to its growing list of product offerings, which also includes a full offering of Sativa, Indica and Hybrid Flower. Co-founded by Seth Rogen and Evan Goldberg in partnership with Canopy Growth Corporation, Houseplant continues to fulfill its promise of supplying the highest quality cannabis products to consumers.
- Market Realist
Cannabis Edibles: October 17 Is Almost Here!
Cannabis edibles legalization is almost here! On Thursday, Canada will finally legalize edibles, infused beverages, and extracts.
- The Motley Fool
Profitable Aphria (TSX:APHA) Stock Earnings Take Centre Stage
Aphria (TSX:APHA)(NYSE:APHA) stock jumped nicely by about 20% this morning after reporting its second profitable earnings this morning.
- Market Realist
What Legalizing Cannabis Means for Mexico
Mexico is fast approaching its October 23 marijuana legalization deadline. Multiple legalization proposals before parliament are creating confusion.
- The Motley Fool
3 Reasons Canopy Growth (TSX:WEED) Stock Is Worth Buying
Canopy Growth (TSX:WEED)(NYSE:CGC) is increasingly looking like a reasonable investment for long-term contrarians willing to take the risk.
- Baystreet
Stocks in play: The Yield Growth Corp.
Announced the appointment of Amber Allen as Head of Sales for Yield Growth's North American retail distribution. ...
- Zacks
Implied Volatility Surging for Canopy Growth (CGC) Stock Options
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
- The Motley Fool
Could Canopy Growth (TSX:WEED) Stock Be Headed to $5?
Should marijuana investors buy Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) on the dip after losing 65% of its value? Or is the stock going to shed another 75%?
CNW GroupCanopy Growth Announces Sale of Stake in AusCann
SMITHS FALLS, ON, Oct. 15, 2019 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth") has sold its 42,087,639 shares in Australian cannabis company AusCann Group Holdings (AusCann) via an off market block trade at $0.15 per share for gross proceeds of $6.3 million. The sale represents Canopy Growth's total 13.2% interest in AusCann. "Canopy Growth remains optimistic about the future of the Australian medical cannabis market and will continue to collaborate with the team at Auscann to support greater physician understanding and patient access to high quality cannabis products throughout Australia," said Mark Zekulin, CEO, Canopy Growth.
- Investing.com
Pot Stocks Gain on Surprise Earnings Beat by Aphria
Investing.com - Pot stocks were higher on Tuesday after upbeat earnings results from Aphria.
CNW GroupCanopy Growth completes previously announced acquisition of Beckley Canopy Therapeutics
SMITHS FALLS, ON & LONDON, Oct. 15, 2019 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth" or the "Company") has closed the previously announced acquisition of all outstanding shares in the global cannabinoid based research company Beckley Canopy Therapeutics (Beckley Canopy), including the joint commercial venture Spectrum Biomedical UK. As a part of the acquisition, Canopy Growth's European management structure will evolve. Paul Steckler and Steven Wooding will assume the roles of Co-Managing Directors in charge of all European operations.
- Baystreet
Cannabis 2.0: Is This ETF Discounted?
Before the 2015 federal election in Canada, cannabis stocks were prepping for a run that would christen ...
